LU91326I2 - Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé) - Google Patents
Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé)Info
- Publication number
- LU91326I2 LU91326I2 LU91326C LU91326C LU91326I2 LU 91326 I2 LU91326 I2 LU 91326I2 LU 91326 C LU91326 C LU 91326C LU 91326 C LU91326 C LU 91326C LU 91326 I2 LU91326 I2 LU 91326I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- recombinant
- adsorbed
- human papillomavirus
- papillomavirus vaccine
- vaccine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12652899P | 1999-03-26 | 1999-03-26 | |
US09/524,624 US6245568B1 (en) | 1999-03-26 | 2000-03-13 | Human papilloma virus vaccine with disassembled and reassembled virus-like particles |
PCT/US2000/007595 WO2000057906A1 (fr) | 1999-03-26 | 2000-03-22 | Vaccin contre le papillomavirus aux particules viro-induites desassemblees et reassemblees |
Publications (2)
Publication Number | Publication Date |
---|---|
LU91326I2 true LU91326I2 (fr) | 2007-05-14 |
LU91326I9 LU91326I9 (fr) | 2018-12-31 |
Family
ID=26824774
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91326C LU91326I2 (fr) | 1999-03-26 | 2007-03-13 | Vaccin papillomavirus humain Ä6,11,16,18Ü(recombinant, adsorbé) |
LU91328C LU91328I2 (fr) | 1999-03-26 | 2007-03-13 | Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé) |
LU91327C LU91327I2 (fr) | 1999-03-26 | 2007-03-13 | Vaccin papillomavirus humain Ätypes 56,11,16,18Ü(recombinant, adsorbé) |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91328C LU91328I2 (fr) | 1999-03-26 | 2007-03-13 | Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé) |
LU91327C LU91327I2 (fr) | 1999-03-26 | 2007-03-13 | Vaccin papillomavirus humain Ätypes 56,11,16,18Ü(recombinant, adsorbé) |
Country Status (19)
Country | Link |
---|---|
US (2) | US6245568B1 (fr) |
EP (1) | EP1165126B1 (fr) |
JP (1) | JP4594534B2 (fr) |
KR (1) | KR20020013516A (fr) |
AR (1) | AR023166A1 (fr) |
AT (1) | ATE339222T1 (fr) |
AU (1) | AU778937B2 (fr) |
CA (1) | CA2368391C (fr) |
CY (4) | CY1105779T1 (fr) |
DE (4) | DE60030698T2 (fr) |
DK (1) | DK1165126T3 (fr) |
ES (1) | ES2270822T3 (fr) |
FR (1) | FR07C0026I2 (fr) |
LT (1) | LTC1165126I2 (fr) |
LU (3) | LU91326I2 (fr) |
NL (3) | NL300268I1 (fr) |
PT (1) | PT1165126E (fr) |
SI (1) | SI1165126T1 (fr) |
WO (1) | WO2000057906A1 (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7351533B2 (en) | 1997-09-05 | 2008-04-01 | Medimmune, Inc. | In vitro method for disassmbly/reassembly of papillomavirus virus-like particles (VLPs). Homogeneous VLP and cavsomere compositions produced by said methods: use thereof as vehicle for improved purification, and delivery of active agents |
US6962777B1 (en) * | 1997-09-05 | 2005-11-08 | Medimmune, Inc. | In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps), homogeneous vlp and capsomere compositions produced by said methods; use thereof as vehicle for improved purification, and delivery of active agents |
ES2325053T3 (es) * | 1999-12-09 | 2009-08-25 | Medimmune, Llc | Metodo in vitro para desensamblaje/reensamblaje de particulas similares a virus de papilomavirus (vlp). |
EP1409013B1 (fr) * | 2001-07-26 | 2009-11-18 | Novartis Vaccines and Diagnostics S.r.l. | Vaccins comprenant des adjuvants aluminium et histidine |
GB0118249D0 (en) | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
DE10137102A1 (de) * | 2001-07-30 | 2003-02-27 | Deutsches Krebsforsch | Polyvalente Vakzine gegen durch Papillomaviren verursachte Erkrankungen, Verfahren zu deren Herstellung und deren Verwendung |
US20060073530A1 (en) * | 2001-08-15 | 2006-04-06 | Olaf Schneewind | Methods and compositions involving sortase B |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
AU2003217413A1 (en) * | 2002-02-14 | 2003-09-04 | Novavax, Inc. | Method for isolation and purification of expressed gene products in vitro |
GB0206360D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
GB0206359D0 (en) * | 2002-03-18 | 2002-05-01 | Glaxosmithkline Biolog Sa | Viral antigens |
DE10237639A1 (de) * | 2002-08-13 | 2004-02-26 | Martin-Luther-Universität Halle-Wittenberg | Verfahren zur Herstellung von virusanalogen Partikeln durch in vitro-Assemblierung von Kapsomeren oder von Kapsomeren, an die biologisch aktive Makromoleküle gebunden sind, bei gleichzeitiger Verpackung der Makromoleküle |
GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
KR101130948B1 (ko) | 2002-11-01 | 2012-03-30 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 건조 공정 |
US7858098B2 (en) * | 2002-12-20 | 2010-12-28 | Glaxosmithkline Biologicals, S.A. | Vaccine |
NZ540811A (en) | 2002-12-20 | 2007-03-30 | Glaxosmithkline Biolog S | Use of HPV 16 and HPV 18 VLPs in the prevention of infection or disease caused by one or more of the group of oncogenic HPV types excluding types 16 and 18 |
JP4734608B2 (ja) * | 2004-07-01 | 2011-07-27 | 国立大学法人東京工業大学 | 生理的条件下でのウイルス粒子様構造体及びその形成方法 |
US7906024B2 (en) * | 2005-01-25 | 2011-03-15 | Wyeth Research Ireland Limited | Shear protectants in harvest microfiltration |
JP2009501520A (ja) * | 2005-07-14 | 2009-01-22 | メイヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | パラミクソウイルス科ウイルス調製物 |
US20090105130A1 (en) * | 2005-08-12 | 2009-04-23 | Astellas Pharma Inc. | Depsipeptide-containing injection solution |
CN101291689B (zh) * | 2005-09-01 | 2012-12-05 | 若泽·路易斯·努诺·阿雅拉 | 用于大规模接种系统的活抗原的疫苗稳定化制剂 |
TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
CA2652118C (fr) * | 2006-05-11 | 2015-07-07 | Becton, Dickinson And Company | Methode d'extraction de proteines a partir de cellules |
US9207240B2 (en) * | 2007-11-14 | 2015-12-08 | Arbor Vita Corporation | Method of efficient extraction of protein from cells |
US8420128B2 (en) * | 2008-03-31 | 2013-04-16 | Morinaga Milk Industry Co., Ltd. | Method of imparting heat resistance to lactoferrin |
JP5916610B2 (ja) | 2009-09-03 | 2016-05-11 | ベクトン・ディキンソン・アンド・カンパニーBecton, Dickinson And Company | 直接的な化学的溶解のための方法および組成物 |
EP3831406B1 (fr) | 2010-08-23 | 2024-06-05 | Wyeth LLC | Formulations stables des antigènes rlp2086 de neisseria meningitidis |
AU2011300409B2 (en) | 2010-09-10 | 2015-03-26 | Wyeth Llc | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens |
MX351993B (es) | 2012-03-09 | 2017-11-03 | Pfizer | Composiciones de neisseria meningitidis y metodos de las mismas. |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
CN104203270A (zh) | 2012-03-18 | 2014-12-10 | 葛兰素史密丝克莱恩生物有限公司 | 针对人乳头状瘤病毒的接种方法 |
KR101559622B1 (ko) * | 2012-07-30 | 2015-10-13 | 중앙대학교 산학협력단 | 인유두종바이러스 바이러스 유사입자의 고효율 정제방법 |
CA2903716C (fr) | 2013-03-08 | 2019-04-09 | Pfizer Inc. | Polypeptides immunogenes de fusion |
MX369534B (es) | 2013-09-08 | 2019-11-11 | Pfizer | Composiciones de neisseria meningitidis y sus metodos. |
RU2723045C2 (ru) | 2015-02-19 | 2020-06-08 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их получения |
JP7010961B2 (ja) | 2017-01-31 | 2022-02-10 | ファイザー・インク | 髄膜炎菌組成物およびその方法 |
US20200010850A1 (en) | 2017-02-17 | 2020-01-09 | The USA, as represeented by the Secretary, Dept. of Health and Human Services | Efficient cell free production of papillomavirus gene transfer vectors |
CN110987571A (zh) * | 2019-12-31 | 2020-04-10 | 广州金域医学检验中心有限公司 | 一种单克隆多聚体m蛋白解聚方法 |
CN111812313B (zh) * | 2020-06-22 | 2021-10-08 | 北京生物制品研究所有限责任公司 | 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0971696B1 (fr) * | 1997-02-06 | 2010-06-09 | Merck Sharp & Dohme Corp. | Conservateurs sans thimerosal pour vaccins |
WO1998044944A2 (fr) | 1997-04-08 | 1998-10-15 | Merck & Co., Inc. | Formulations stabilisees du virus du papillome humain |
JP2002510976A (ja) | 1997-07-03 | 2002-04-09 | ユニバーシティ・オブ・コロラド・ユニバーシティ・テクノロジー・コーポレイション | 均質のヒト・パピローマウイルスのカプソメアを含有する組成物、その製造方法、およびその診断的、予防的、治療的使用 |
-
2000
- 2000-03-13 US US09/524,624 patent/US6245568B1/en not_active Expired - Lifetime
- 2000-03-22 AU AU39093/00A patent/AU778937B2/en not_active Expired
- 2000-03-22 EP EP00918248A patent/EP1165126B1/fr not_active Expired - Lifetime
- 2000-03-22 PT PT00918248T patent/PT1165126E/pt unknown
- 2000-03-22 AT AT00918248T patent/ATE339222T1/de active
- 2000-03-22 DE DE60030698T patent/DE60030698T2/de not_active Expired - Lifetime
- 2000-03-22 WO PCT/US2000/007595 patent/WO2000057906A1/fr active IP Right Grant
- 2000-03-22 CA CA2368391A patent/CA2368391C/fr not_active Expired - Lifetime
- 2000-03-22 DE DE200712000033 patent/DE122007000033I1/de active Pending
- 2000-03-22 KR KR1020017012229A patent/KR20020013516A/ko not_active Application Discontinuation
- 2000-03-22 DE DE200712000034 patent/DE122007000034I1/de active Pending
- 2000-03-22 ES ES00918248T patent/ES2270822T3/es not_active Expired - Lifetime
- 2000-03-22 DE DE200712000032 patent/DE122007000032I1/de active Pending
- 2000-03-22 DK DK00918248T patent/DK1165126T3/da active
- 2000-03-22 JP JP2000607656A patent/JP4594534B2/ja not_active Expired - Lifetime
- 2000-03-22 SI SI200030893T patent/SI1165126T1/sl unknown
- 2000-03-24 AR ARP000101345A patent/AR023166A1/es unknown
-
2001
- 2001-01-30 US US09/772,365 patent/US20010021385A1/en not_active Abandoned
-
2006
- 2006-11-14 CY CY20061101649T patent/CY1105779T1/el unknown
-
2007
- 2007-03-13 LU LU91326C patent/LU91326I2/fr unknown
- 2007-03-13 NL NL300268C patent/NL300268I1/nl unknown
- 2007-03-13 LU LU91328C patent/LU91328I2/fr unknown
- 2007-03-13 NL NL300270C patent/NL300270I1/nl unknown
- 2007-03-13 NL NL300269C patent/NL300269I2/nl unknown
- 2007-03-13 LU LU91327C patent/LU91327I2/fr unknown
- 2007-03-16 CY CY2007009C patent/CY2007009I2/el unknown
- 2007-03-16 CY CY200700010C patent/CY2007010I2/el unknown
- 2007-03-16 CY CY200700008C patent/CY2007008I1/el unknown
- 2007-03-19 LT LTPA2007002C patent/LTC1165126I2/lt unknown
- 2007-03-20 FR FR07C0026C patent/FR07C0026I2/fr active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91328I2 (fr) | Vaccin papillomavirus humain Ätypes 6,11,16,18Ü(recombinant, adsorbé) | |
ATE413188T1 (de) | Menschliche papillomavirus impfstoff- formulierungen | |
IL158107A0 (en) | Human papillomaviruses vaccine | |
DZ2462A1 (fr) | Vaccin antigrippal. | |
NO20014322L (no) | Vaksine | |
DK1023904T3 (da) | Adjuvanser til anvendelse i vacciner | |
ATE490327T1 (de) | Impfstoffzusammensetzung | |
DZ3219A1 (fr) | Vaccin | |
IL150961A0 (en) | Human immunodeficiency virus vaccine | |
DZ2283A1 (fr) | Composition de vaccin. | |
IL189736A0 (en) | Vaccine adjuvants | |
EP1389043A4 (fr) | Vaccin contre le virus de la maladie de la fievre aphteuse | |
GB9915204D0 (en) | Vaccine | |
HUP0202770A3 (en) | Human papilloma virus vaccine | |
IS2797B (is) | Bóluefni gegn ISA-veiru | |
IL151033A0 (en) | Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use | |
GB9906437D0 (en) | Vaccine | |
GB9913327D0 (en) | Vaccine | |
GB9911823D0 (en) | New vaccine formulations | |
NO20002213D0 (no) | Babesia vaksine | |
GB9909072D0 (en) | Vaccine | |
FR2730936B1 (fr) | Vaccin presentant une immunogenicite accrue | |
ITMI992410A0 (it) | Vaccino per hiv | |
GB9917981D0 (en) | Viral vaccine | |
GB9911825D0 (en) | New vaccine formulations |